Requirements for the appointment of the contact person for pharmacovigilance issues are specified in the PHV-6 Guideline (applicable from Jul. 1, 2013).
Home
/
Medicines
/
Pharmacovigilance
/
Documents for pharmacovigilance branch
/
Questions and answers on the amended Act on...
/
PSMF – Pharmacovigilance system master file and...
/
Appointment of the contact person for PV issues...